Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KSO-0400 in BPH Patients With LUTS
NCT01222650Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silodosin in benign prostatic hyperplasia (BPH), sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.
02
Drugs
silodosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01222650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222650.